Novavax Inc SEC filings NVAX
Novavax Inc has 1,003 filings in SEC EDGAR's recent list, going back to Feb 14, 2013. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 27, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 28, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 28, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| 10-K/A | Amended annual report | Apr 30, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 1, 2021 | Dec 31, 2020 |
| 10-K/A | Amended annual report | Apr 29, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 11, 2020 | Dec 31, 2019 |
| 10-K/A | Amended annual report | Apr 30, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 18, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 14, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Feb 27, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Feb 29, 2016 | Dec 31, 2015 |
| ARS | Annual report to shareholders | May 7, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Feb 27, 2015 | Dec 31, 2014 |
| ARS | Annual report to shareholders | May 13, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Mar 12, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Mar 12, 2013 | Dec 31, 2012 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- NVAX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Gaithersburg, MD
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1000694
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.